Clinical trial

Central Pain Study for ABX-1431

NCT03138421

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-08-01

PhasePHASE1

Study timeline

Study start (actual)2017-08-01Date precision: day

Registry last updated2019-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neuromyelitis Optica Spectrum Disorderunresolved

Transverse Myelitisunresolved

Multiple Sclerosisunresolved

Longitudinally Extensive Transverse Myelitisunresolved

Interventions

ABX-1431 HClDRUG

Sponsors & collaborators

Abide Therapeuticslead sponsor

Mapped research locations

LiverpoolUnited Kingdom1 OxfordUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03138421 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.